6934 — Hcmed Innovations Co Cashflow Statement
0.000.00%
Last trade - 00:00- TWD4.24bn
- TWD4.06bn
- TWD141.61m
Annual cashflow statement for Hcmed Innovations Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -40.2 | -144 | -166 | -50.9 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 15.1 | 40 | 22.8 | 24.7 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -3.75 | 9.49 | 8.78 | -30.4 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -19.8 | -80.4 | -112 | -32.5 |
| Capital Expenditures | -5.32 | -7.96 | -16.4 | -11.4 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -7.17 | -0.157 | -179 | 55.8 |
| Sale of Business | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -12.5 | -8.12 | -195 | 44.5 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -5.14 | 164 | 250 | -13.1 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -37.5 | 75 | -56.9 | -0.789 |